Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver G Ottmann

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Blood|October 8, 2020
TKI vs relapse after HSCT: is the jury still out?Oliver G Ottmann
Best Practice & Research. Clinical Haematology|March 6, 2003
Imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia: current status and evolving conceptsOliver G Ottmann, Barbara Wassmann
The Hematology Journal : the Official Journal of the European Haematology Association|April 18, 2002
The ABL tyrosine kinase inhibitor STI571 (Glivec) in Philadelphia positive acute lymphoblastic leukemia - promises, pitfalls and possibilitiesOliver G Ottmann, Dieter Hoelzer
Current Opinion in Oncology|June 30, 2009
First-line treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in adultsOliver G Ottmann, Heike Pfeifer
Hematology. American Society of Hematology. Education Program|December 17, 2009
Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)Oliver G Ottmann, Heike Pfeifer
Investigational New Drugs|December 15, 2010
The DAC system and associations with acute leukemias and myelodysplastic syndromesGesine Bug, Oliver G Ottmann
Hematology. American Society of Hematology. Education Program|November 24, 2005
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemiaOliver G Ottmann, Barbara Wassmann
Blood|February 6, 2025
Asciminib for Ph+ ALL: a step forward?Fabian Lang, Oliver G Ottmann
Seminars in Hematology|November 26, 2002
Targeted therapies in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemiaDieter Hoelzer, Nicola Gökbuget, Oliver G Ottmann
European Journal of Immunology|March 3, 2004
Regulation of human IL-18 gene expression: interaction of PU.1 with GC-box binding protein is involved in human IL-18 expression in myeloid cellsNoriko Koyama, Dieter Hoelzer, Oliver G Ottmann
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Blood|October 8, 2020
TKI vs relapse after HSCT: is the jury still out?Oliver G Ottmann
Best Practice & Research. Clinical Haematology|March 6, 2003
Imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia: current status and evolving conceptsOliver G Ottmann, Barbara Wassmann
The Hematology Journal : the Official Journal of the European Haematology Association|April 18, 2002
The ABL tyrosine kinase inhibitor STI571 (Glivec) in Philadelphia positive acute lymphoblastic leukemia - promises, pitfalls and possibilitiesOliver G Ottmann, Dieter Hoelzer
Current Opinion in Oncology|June 30, 2009
First-line treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in adultsOliver G Ottmann, Heike Pfeifer
Hematology. American Society of Hematology. Education Program|December 17, 2009
Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)Oliver G Ottmann, Heike Pfeifer
Investigational New Drugs|December 15, 2010
The DAC system and associations with acute leukemias and myelodysplastic syndromesGesine Bug, Oliver G Ottmann
Hematology. American Society of Hematology. Education Program|November 24, 2005
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemiaOliver G Ottmann, Barbara Wassmann
Blood|February 6, 2025
Asciminib for Ph+ ALL: a step forward?Fabian Lang, Oliver G Ottmann
Seminars in Hematology|November 26, 2002
Targeted therapies in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemiaDieter Hoelzer, Nicola Gökbuget, Oliver G Ottmann
European Journal of Immunology|March 3, 2004
Regulation of human IL-18 gene expression: interaction of PU.1 with GC-box binding protein is involved in human IL-18 expression in myeloid cellsNoriko Koyama, Dieter Hoelzer, Oliver G Ottmann
Pageof 11